| David |
foresiGHt, NCT04615273 / 2020-000929-42: A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency |
|
|
| Completed | 3 | 264 | Europe, Canada, Japan, US, RoW | Lonapegsomatropin, Placebo, Somatropin | Ascendis Pharma Endocrinology Division A/S | Growth Hormone Deficiency, Endocrine System Diseases, Hormone Deficiency | 11/23 | 12/23 | | |
NCT06254950: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis |
|
|
| Recruiting | 2 | 207 | Europe, Canada, Japan, US, RoW | TAK-279, Zasocitinib, Placebo | Takeda | Ulcerative Colitis | 09/26 | 08/27 | | |
| Recruiting | 1 | 30 | US | PH-762 | Phio Pharmaceuticals Inc., Prosoft Clinical | Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin | 06/25 | 09/25 | | |
NCT05468957: Comparing Perclose to Statseal in Conjunction with Perclose in Femoral 6 French Arteriotomy Closure |
|
|
| Recruiting | N/A | 150 | US | Perclose, Suture based hemostasis device, Statseal, potassium ferrate disc with topical hydrophilic polymer | University of California, Los Angeles | Arterial Occlusion, Cardiovascular Diseases, Atherosclerosis, Hematoma | 06/25 | 07/25 | | |
| Recruiting | N/A | 120 | RoW | Software refraction with Eye Test Technology in a mobilerone, Online refraction or App refraction with Eye Test Technology, Retinoscopy, Refraction by retinoscopy | Beijing Airdoc Technology Co., Ltd., University of Notre Dame Australia | Myopia, Myopia, Moderate, Astigmatism | 12/25 | 12/30 | | |
